Work

Trial in Progress: Phase I Dose-Escalation and Dose-Expansion Trial of a Novel Glutaminase Inhibitor (CB-839 HCl) in Combination with Carfilzomib and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-123399

Authors: Wilson I Gonsalves, Srinivas Devarakonda, Rachid Baz, Natalia Neparidze, Alex A Adjei, Charles Kunos, Shaji K. Kumar

Institutions: Mayo Clinic, The Ohio State University, Moffitt Cancer Center, Yale Cancer Center, National Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2985733931

Cites:

Cited by: 4

Related to: 10